Daridorexant
Daridorexant has adult insomnia efficacy and is considered safe in adults aged 18 years and older. Daridorexant is approved for adult insomnia at 25 mg and 50 mg in multiple jurisdictions. Daridorexant is being studied as the first control…
1 sources - 4 claims
Daridorexant has adult insomnia efficacy and is considered safe in adults aged 18 years and older. Daridorexant is approved for adult insomnia at 25 mg and 50 mg in multiple jurisdictions. Daridorexant is being studied as the first controlled paediatric trial of a DORA in children and adolescents with insomnia disorder. Daridorexant blocks orexin 1 and orexin 2 receptors to inhibit the wake-promoting orexin pathway.